T cells, interleukin-2 and systemic lupus erythematosus—from pathophysiology to therapy
A Mak - Cells, 2022 - mdpi.com
The phenotypic and functional complexities of T cells engender complicated and often
confusing concepts as to how T cells ignite, accelerate and brake the inflammatory …
confusing concepts as to how T cells ignite, accelerate and brake the inflammatory …
[HTML][HTML] Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease
A robust adaptive immune response is essential for combatting pathogens. In the wrong
context such as due to genetic and environmental factors, however, the same mechanisms …
context such as due to genetic and environmental factors, however, the same mechanisms …
Deferoxamine-Loaded Injectable Chitosan-Grafted Chlorogenic Acid/Oxidized Hyaluronic Acid Hybrid Hydrogel with Antibacterial, Anti-inflammatory, and …
H Zhong, Y Fang, M Luo, L Wang… - … Applied Materials & …, 2024 - ACS Publications
Diabetic chronic wounds are notoriously difficult to heal as a result of their susceptibility to
infection. To address this issue, we constructed an innovated and adaptable solution in the …
infection. To address this issue, we constructed an innovated and adaptable solution in the …
[HTML][HTML] Hymecromone Promotes Longevity and Insulin Sensitivity in Mice
N Nagy, KS Czepiel, G Kaber, D Stefanovski, A Hargil… - Cells, 2024 - mdpi.com
Given that the extracellular matrix polymer hyaluronan (HA) has been implicated in
longevity, we asked whether 4-methylumbelliferone (4-MU), an inhibitor of HA synthesis …
longevity, we asked whether 4-methylumbelliferone (4-MU), an inhibitor of HA synthesis …
Syntaxin 4 enrichment in β-cells prevents conversion to autoimmune diabetes in non-obese diabetic (NOD) mice
E Oh, EM McCown, M Ahn, PA Garcia… - Diabetes, 2021 - Am Diabetes Assoc
Syntaxin 4 (STX4), a plasma membrane–localized SNARE protein, regulates human islet β-
cell insulin secretion and preservation of β-cell mass. We found that human type 1 diabetes …
cell insulin secretion and preservation of β-cell mass. We found that human type 1 diabetes …
Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
JT Ding, KP Yang, KL Lin, YK Cao, F Zou - Frontiers in Endocrinology, 2023 - frontiersin.org
Background Considered a significant risk to health and survival, type 1 diabetes (T1D) is a
heterogeneous autoimmune disease characterized by hyperglycemia caused by an …
heterogeneous autoimmune disease characterized by hyperglycemia caused by an …
Advancing Animal Models of Human Type 1 Diabetes
DV Serreze, JR Dwyer… - Cold Spring …, 2024 - perspectivesinmedicine.cshlp.org
Multiple rodent models have been developed to study the basis of type 1 diabetes (T1D).
However, nonobese diabetic (NOD) mice and derivative strains still provide the gold …
However, nonobese diabetic (NOD) mice and derivative strains still provide the gold …
The collagen matrix regulates the survival and function of pancreatic islets
Y Zhu, M Yang, W Xu, Y Zhang, L Pan, L Wang… - Endocrine, 2024 - Springer
The extracellular matrix (ECM) provides an appropriate microenvironment for many kinds of
cells, including pancreatic cells. Collagens are the most abundant components of the ECM …
cells, including pancreatic cells. Collagens are the most abundant components of the ECM …
Controlled release of bioactive IL-2 from visible light photocured biodegradable elastomers for cancer immunotherapy applications
MA Shaker, JJE Doré, HM Younes - … Development and Technology, 2022 - Taylor & Francis
Biodegradable elastomeric controlled-release poly (decane-co-tricarballylate)(PDET) based
matrices capable of maintaining the stability and bioactivity of Interleukin-2 (IL-2) through the …
matrices capable of maintaining the stability and bioactivity of Interleukin-2 (IL-2) through the …
Precision Biomaterials for Modulating Regulatory T cells
P Hadley - 2024 - escholarship.org
Over the past few decades, regulatory T cell (Treg) therapy has gained traction for the
treatment of autoimmunity, transplant rejection, and other inflammatory diseases. A …
treatment of autoimmunity, transplant rejection, and other inflammatory diseases. A …